Latest AI and machine learning research in other cancers for healthcare professionals.
BACKGROUND: Real-time breath metabolomic profiling may detect lung cancer-associated breath features...
BACKGROUND: Hepatocellular carcinoma (HCC) frequently develops in the setting of chronic hepatitis B...
Tertiary lymphoid structures (TLS) are organized ectopic immune aggregates within the tumor microenv...
Fibroblast growth factor receptor (FGFR) alterations have emerged as clinically actionable biomarker...
The pressing need for high-fidelity in vitro tumor models that accurately recapitulate the native tu...
BACKGROUND: Esophageal adenocarcinoma (EAC) remains a lethal malignancy with limited prognostic tool...
INTRODUCTION: The combination of CDK4/6 inhibitors and endocrine therapy is the first-line standard ...
Epstein-Barr virus associated gastric carcinoma (EBVaGC) represents a distinct molecular subtype of ...
A detailed understanding of solid-state reaction pathways is essential for connecting predictive fra...
Artificial intelligence (AI) is rapidly moving from conceptual innovation to high-performing algorit...
Immune checkpoint blockade (ICB) can produce durable responses in cancer, but reliable predictors of...
BACKGROUND: Colorectal cancer (CRC) exhibits substantial metabolic heterogeneity. This study develop...
BACKGROUND: The rapid advancement of digital pathology has opened unprecedented opportunities for in...
PURPOSE: The clinical outcome of urothelial carcinoma presents significant variability, reflecting i...
PURPOSE: This study aimed to evaluate the clinical value of deep learning image reconstruction (DLIR...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer...
BACKGROUND: Nursing ethics guides practice, but European Union national codes were developed in dive...
Hepatocellular carcinoma (HCC) is a biologically heterogeneous malignancy staged according to tumor ...
BACKGROUND: The AI-HOPE Lung Cancer study is a multicenter initiative designed to integrate artifici...
Lung adenocarcinoma (LUAD) exhibits considerable heterogeneity and therapeutic resistance. Here, we ...
Noninvasive diagnosis and longitudinal surveillance of urothelial carcinoma (UC) remain clinically c...